30247-86-0

Basic information

• Product Name: Benzoic acid, 2-(chlorocarbonyl)- (9CI)
• Synonyms: Benzoic acid, 2-(chlorocarbonyl)- (9CI);Phthalic acid 1-chloride
• CAS NO: 30247-86-0
• Molecular Formula: C₈H₅ClO₃
• Molecular Weight: 184.5765
• Product Categories: ACIDHALIDE
• Mol File: 30247-86-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 334.2±25.0 °C(Predicted)
• Appearance: /
• Density: 1.437±0.06 g/cm3(Predicted)
• PKA: 3.26±0.36(Predicted)
• CAS DataBase Reference: Benzoic acid, 2-(chlorocarbonyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-(chlorocarbonyl)- (9CI)(30247-86-0)
• EPA Substance Registry System: Benzoic acid, 2-(chlorocarbonyl)- (9CI)(30247-86-0)

Safety Data

• Hazardous Substances Data: 30247-86-0(Hazardous Substances Data)

Upstream product

• 529-34-0 3,4-dihydronaphthalene-1(2H)-one 
• 88-99-3 benzene-1,2-dicarboxylic acid 
• 1821-12-1 4-Phenylbutyric acid 
• 2051-95-8 succinylbenzene 
• 71-43-2 benzene 

Downstream Products

• 38920-31-9 N-[4-(1-Amino-4-hydroxy-9,10-dioxo-9,10-dihydro-anthracen-2-yloxy)-phenyl]-phthalamic acid 
• 121003-48-3 Sodium; (6R,7R)-3-acetoxymethyl-7-(2-carboxy-benzoylamino)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylate 
• 37044-50-1 2-(1-phenyl-1H-benzo[d]imidazol-2-yl)benzoic acid 
• 37135-50-5 2-((2-(phenylamino)phenyl)carbamoyl)benzoic acid 
• 5211-78-9 2-carboxyphenyl 2-hydroxy-4-methylphenylmethanone 
• 38119-03-8 2-[2]naphthoyl-benzoic acid 
• 5018-87-1 2-(naphthalene-1-carbonyl)-benzoic acid 
• 56-55-3 benz[a]anthracene 
• 1309375-81-2 C₃₆H₃₈N₄O₄ 
• 185019-41-4 S-methyl-N-nitro-N'-phthaloyl-isothiourea 
• 6340-29-0 2-(2-carboxyphenyl)benzothiazole 
• 19795-35-8 2-(oxo-4H-benzo[d][1,3]oxazin-2-yl)-benzoic acid 
• 20320-37-0 2-(dimethylaminocarbonyl)benzoic acid 

Relevant articles and documents

Ru(ii)-catalyzed allenylation and sequential annulation of: N -tosylbenzamides with propargyl alcohols

We hereby report Ru(ii)-catalyzed C(sp2)-H allenylation of N-tosylbenzamides to access multi-substituted allenylamides. Furthermore, the allenylamides were converted to the corresponding isoquinolone derivatives via base mediated annulation. The current protocol features low catalyst loading, mild reaction conditions, high functional group compatibility and desired scalability. The unique functionality of the afforded allenes allowed further transformations to expand the practicality of the protocol. This journal is